gastric cancer Archives -

Merck & Co’s Keytruda become the first cancer immunotherapy to be approved as a first-line oesophageal cancer treatment

BMS strikes back against Merck in EU oesophageal cancer market

https://pharmaphorum.com/news/bms-strikes-back-against-merck-in-eu-oesophageal-cancer-market/

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Imugene HER2 vaccine hits target in stomach cancer trial

Phil Taylor Australia, Biotech, cancer vaccine, gastric cancer, immuno-oncology, Imugene, Oncology 0 Comment

A peptide vaccine developed by Australia’s Imugene has reduced tumour size in around half of patients with HER2-positive

Imugene HER2 vaccine hits target in stomach cancer trial

https://pharmaphorum.com/news/imugene-her2-vaccine-hits-target-in-stomach-cancer-trial/

News/ News/ Oncology

Merck pulls Keytruda’s FDA nod for third-line stomach cancer

Phil Taylor fda, gastric cancer, immuno-oncology, Keytruda, Merck & Co, Oncology, regulatory approval 0 Comment

Merck & Co will voluntarily withdraw a US marketing approval for cancer immunotherapy blockbuster Keytruda in gastric cancer,

Merck pulls Keytruda’s FDA nod for third-line stomach cancer

https://pharmaphorum.com/news/merck-pulls-keytrudas-fda-nod-for-third-line-stomach-cancer/

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

News/ News/ R&D

Amgen in $1.9bn swoop for Five Prime and its gastric cancer drug

Richard Staines Amgen, cancer, Five Prime Therapeutics, gastric cancer, R&D 0 Comment

Amgen is to buy US biotech Five Prime Therapeutics for around $1.9 billion, adding a potential gastric cancer

Amgen in $1.9bn swoop for Five Prime and its gastric cancer drug

https://pharmaphorum.com/news/amgen-in-1-9bn-swoop-for-five-prime-and-its-gastric-cancer-drug/

News/ News/ Oncology

Five Prime eyes financing after positive results with stomach cancer drug

Phil Taylor bemarituzumab, Five Prime Therapeutics, gastric cancer, immuno-oncology, Oncology 0 Comment

Shares in US biotech Five Prime Therapeutics more than tripled after it reported promising trial results with stomach

Five Prime eyes financing after positive results with stomach cancer drug

https://pharmaphorum.com/news/five-prime-eyes-financing-after-positive-results-with-stomach-cancer-drug/

News/ News/ Oncology/ Top stories

FDA fast-tracks Leap’s gastric cancer immunotherapy

Phil Taylor BeiGene, gastric cancer, immuno-oncology, Leap Therapeutics, Oncology 0 Comment

Leap Therapeutics will get a swift FDA review for its lead drug DKN-01 for a form of gastric

FDA fast-tracks Leap’s gastric cancer immunotherapy

https://pharmaphorum.com/news/fda-fast-tracks-leaps-gastric-cancer-immunotherapy/

News/ News/ Oncology/ Top stories

Pieris begins gastric cancer combination trial with Lilly’s Cyramza

Richard Staines Eli Lilly, gastric cancer, Pieris Pharmaceuticals, R&D 0 Comment

US biotech Pieris Pharmaceuticals has begun a collaboration and supply agreement with Eli Lilly, trialling its cancer drug

Pieris begins gastric cancer combination trial with Lilly’s Cyramza

https://pharmaphorum.com/news/pieris-begins-gastric-cancer-combination-trial-with-lillys-cyramza/

AstraZeneca's (AZ) Tagrisso (osimertinib)

News/ News/ Oncology

AstraZeneca to unveil key data for cancer drugs at ASCO

Richard Staines asco, AstraZeneca, cancer, colon cancer, gastric cancer, lung cancer, Oncology 0 Comment

AstraZeneca plans to unveil data at this year’s American Society of Clinical Oncology (ASCO) conference that could expand

AstraZeneca to unveil key data for cancer drugs at ASCO

https://pharmaphorum.com/news/astrazeneca-to-unveil-key-data-for-cancer-drugs-at-asco/

News/ News/ Oncology/ R&D/ US

Merck’s Keytruda fails in gastric cancer trial

Richard Staines Bristol-Myers Squibb, cancer, gastric cancer, immuno-oncology, Merck & Co 0 Comment

Trial missed overall survival endpoint

Merck’s Keytruda fails in gastric cancer trial

https://pharmaphorum.com/news/mercks-keytruda-fails-gastric-cancer-trial/

Trending

gastric cancer

Login